DaVita Inc.
HealthcareNYSE:DVA · New York Stock Exchange
+$4.83 today
Vol 0.74M · Avg 0.85M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $726.4M |
| Short-term Investments | $22.3M |
| Receivables | $3.0B |
| Inventory | $141.6M |
| Other Current | $195.4M |
| Total Current Assets | $4.1B |
| PP&E (Net) | $5.2B |
| Goodwill | $7.6B |
| Intangible Assets | $229.0M |
| Long-term Investments | $39.5M |
| Other Non-current | $434.4M |
| Total Non-current Assets | $13.4B |
| Total Assets | $17.5B |
Analysis
Selected assets total $17.5B for Latest. The largest visible component is Goodwill at $7.6B, about 43.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $757.7M -4.7% | $794.9M +109.2% | $380.1M +55.7% | $244.1M -47.2% | $461.9M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $24.3M -52.4% | $51.1M +339.8% | $11.6M -85.1% | $77.7M +248.2% | $22.3M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $3.0B +15.7% | $2.6B +5.9% | $2.4B -5.3% | $2.6B +5.8% | $2.4B | $533.8M | $399.4M | -$1.7B |
| Inventory | $160.6M +19.4% | $134.6M -6.0% | $143.1M +31.1% | $109.1M +1.6% | $107.4M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $156.3M -24.8% | $207.8M +11.0% | $187.2M +7.8% | $173.7M +86.7% | $93.1M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $4.1B +8.3% | $3.7B +19.4% | $3.1B -0.6% | $3.2B -0.4% | $3.2B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $5.2B -2.3% | $5.3B -4.3% | $5.6B -5.9% | $5.9B -6.1% | $6.3B | $1.2B | $1.5B | $687.8M |
| Goodwill | $7.5B +2.3% | $7.4B +3.7% | $7.1B +0.5% | $7.1B +0.4% | $7.0B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $222.1M +12.5% | $197.4M -2.9% | $203.2M +11.2% | $182.7M +2.8% | $177.7M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $198.2M -46.5% | $370.3M -37.6% | $593.7M +115.6% | $275.4M -4.5% | $288.4M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $246.5M -5.8% | $261.7M -3.5% | $271.3M -14.0% | $315.6M +130.9% | $136.7M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $13.4B -0.9% | $13.5B -1.6% | $13.8B -0.1% | $13.8B -1.3% | $14.0B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $17.5B +1.1% | $17.3B +2.3% | $16.9B -0.2% | $16.9B -1.1% | $17.1B | $13.3B | $11.9B | $10.6B |
| Account Payables | $696.1M +27.2% | $547.2M +6.3% | $514.5M +7.2% | $479.8M +19.3% | $402.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $109.2M -59.7% | $270.9M +119.7% | $123.3M -46.7% | $231.4M +29.3% | $179.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $69.3M +143.1% | $28.5M +58.0% | $18.0M -66.5% | $53.8M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $1.1B -28.7% | $1.5B +7.6% | $1.4B +5.5% | $1.3B +8.9% | $1.2B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $3.1B +5.7% | $3.0B +12.5% | $2.6B +0.9% | $2.6B +9.2% | $2.4B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $12.3B +34.5% | $9.2B +11.0% | $8.3B -4.9% | $8.7B -0.4% | $8.7B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $756.9M +13.8% | $665.4M -8.4% | $726.2M -7.2% | $782.8M -5.8% | $831.0M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | -$2.1B -1333.7% | $169.6M -7.4% | $183.1M +74.0% | $105.2M -11.7% | $119.2M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $13.2B +7.9% | $12.2B +6.2% | $11.5B -4.8% | $12.1B -2.2% | $12.4B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $16.3B +7.4% | $15.2B +7.4% | $14.2B -3.8% | $14.7B -0.3% | $14.8B | $14.7B | $3.7B | $9.6B |
| Common Stock | $69.0K -23.3% | $90.0K +1.1% | $89.0K -1.1% | $90.0K -7.2% | $97.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$328.4M -121.4% | $1.5B +156.5% | $598.3M +242.9% | $174.5M -50.8% | $354.3M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$122.8M +60.5% | -$310.8M -496.7% | -$52.1M +24.7% | -$69.2M +50.3% | -$139.2M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $1.8B -8.2% | $2.0B +16.8% | $1.7B +11.6% | $1.5B -6.4% | $1.6B | $1.4B | $337.8M | $931.4M |
| Total Equity | $1.2B -44.6% | $2.1B -23.8% | $2.7B +23.3% | $2.2B -6.2% | $2.4B | $9.1B | $7.7B | $3.3B |
| Total Debt | $15.0B +24.7% | $12.1B +8.5% | $11.1B -6.0% | $11.8B -1.3% | $12.0B | $724.2M | $410.6M | $399.4M |
| Net Debt | $14.3B +26.8% | $11.3B +5.0% | $10.7B -7.3% | $11.6B +0.6% | $11.5B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$32.71B
Align Technology, Inc.
NASDAQ:ALGN
$12.52B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.81B
Molina Healthcare, Inc.
NYSE:MOH
$10.43B
Henry Schein, Inc.
NASDAQ:HSIC
$9.26B
Universal Health Services, Inc.
NYSE:UHS
$9.17B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.73B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.73B
AptarGroup, Inc.
NYSE:ATR
$7.51B
Chemed Corporation
NYSE:CHE
$5.57B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does DVA have?
DaVita Inc. (DVA) reported $757.75M in cash and equivalents in fiscal 2025.
How much debt does DVA carry?
DaVita Inc. (DVA) reported $15.05B of total debt, with net debt of $14.29B.
Explore More
Continue the stock analysis
Jump to another research area for this company.